These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 37162724)

  • 1. Apoptotic Factors and Mitochondrial Complexes Assist Determination of Strain-Specific Susceptibility of Mice to Parkinsonian Neurotoxin MPTP.
    Yarreiphang H; Vidyadhara DJ; Nambisan AK; Raju TR; Sagar BKC; Alladi PA
    Mol Neurobiol; 2023 Aug; 60(8):4778-4794. PubMed ID: 37162724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Admixing of MPTP-Resistant and Susceptible Mice Strains Augments Nigrostriatal Neuronal Correlates to Resist MPTP-Induced Neurodegeneration.
    Vidyadhara DJ; Yarreiphang H; Raju TR; Alladi PA
    Mol Neurobiol; 2017 Oct; 54(8):6148-6162. PubMed ID: 27704331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Admixing MPTP-resistant and MPTP-vulnerable mice enhances striatal field potentials and calbindin-D28K expression to avert motor behaviour deficits.
    Vidyadhara DJ; Sasidharan A; Kutty BM; Raju TR; Alladi PA
    Behav Brain Res; 2019 Mar; 360():216-227. PubMed ID: 30529402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of spinal motor neurons and alteration of alpha-synuclein immunostaining in MPTP induced Parkinsonism in mice.
    Vivacqua G; Biagioni F; Yu S; Casini A; Bucci D; D'Este L; Fornai F
    J Chem Neuroanat; 2012 Jul; 44(2):76-85. PubMed ID: 22580273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-synuclein up-regulation in substantia nigra dopaminergic neurons following administration of the parkinsonian toxin MPTP.
    Vila M; Vukosavic S; Jackson-Lewis V; Neystat M; Jakowec M; Przedborski S
    J Neurochem; 2000 Feb; 74(2):721-9. PubMed ID: 10646524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in Neuronal Numbers, Morphology, and Developmental Apoptosis in Mice Nigra Provide Experimental Evidence of Ontogenic Origin of Vulnerability to Parkinson's Disease.
    Vidyadhara DJ; Yarreiphang H; Raju TR; Alladi PA
    Neurotox Res; 2021 Dec; 39(6):1892-1907. PubMed ID: 34762290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of Parkinson's disease-associated alpha-synucleinA53T by recombinant adeno-associated virus in mice does not increase the vulnerability of dopaminergic neurons to MPTP.
    Dong Z; Ferger B; Feldon J; Büeler H
    J Neurobiol; 2002 Oct; 53(1):1-10. PubMed ID: 12360578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The TrkB-positive dopaminergic neurons are less sensitive to MPTP insult in the substantia nigra of adult C57/BL mice.
    Ding YX; Xia Y; Jiao XY; Duan L; Yu J; Wang X; Chen LW
    Neurochem Res; 2011 Oct; 36(10):1759-66. PubMed ID: 21562748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of mitochondrial phenotypes by endurance exercise contributes to neuroprotection against a MPTP-induced animal model of PD.
    Jang Y; Kwon I; Song W; Cosio-Lima LM; Taylor S; Lee Y
    Life Sci; 2018 Sep; 209():455-465. PubMed ID: 30144449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Divergent Expression Patterns of Drp1 and HSD10 in the Nigro-Striatum of Two Mice Strains Based on their MPTP Susceptibility.
    Seshadri A; Alladi PA
    Neurotox Res; 2019 Jul; 36(1):27-38. PubMed ID: 30993548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel FABP3 ligand, HY-11-9, ameliorates neuropathological deficits in MPTP-induced Parkinsonism in mice.
    Wang H; Fukunaga K; Cheng A; Wang Y; Arimura N; Yoshino H; Sasaki T; Kawahata I
    J Pharmacol Sci; 2023 May; 152(1):30-38. PubMed ID: 37059489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-related biphasic effect of the Parkinson's disease neurotoxin MPTP, on the spread, accumulation, and toxicity of α-synuclein.
    Merghani MM; Ardah MT; Al Shamsi M; Kitada T; Haque ME
    Neurotoxicology; 2021 May; 84():41-52. PubMed ID: 33549656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combining nitric oxide release with anti-inflammatory activity preserves nigrostriatal dopaminergic innervation and prevents motor impairment in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.
    L'Episcopo F; Tirolo C; Caniglia S; Testa N; Serra PA; Impagnatiello F; Morale MC; Marchetti B
    J Neuroinflammation; 2010 Nov; 7():83. PubMed ID: 21092260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association Between Decreased Srpk3 Expression and Increased Substantia Nigra Alpha-Synuclein Level in an MPTP-Induced Parkinson's Disease Mouse Model.
    Seo MH; Yeo S
    Mol Neurobiol; 2023 Feb; 60(2):780-788. PubMed ID: 36369636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased expression of serum- and glucocorticoid-inducible kinase 1 (SGK1) promotes alpha-synuclein increase related with down-regulation of dopaminergic cell in the Substantia Nigra of chronic MPTP-induced Parkinsonism mice and in SH-SY5Y cells.
    Yeo S; Sung B; Hong YM; van den Noort M; Bosch P; Lee SH; Song J; Park SK; Lim S
    Gene; 2018 Jun; 661():189-195. PubMed ID: 29604467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Neuroprotective Effects of GPR4 Inhibition through the Attenuation of Caspase Mediated Apoptotic Cell Death in an MPTP Induced Mouse Model of Parkinson's Disease.
    Haque ME; Azam S; Akther M; Cho DY; Kim IS; Choi DK
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial permeability transition pore component cyclophilin D distinguishes nigrostriatal dopaminergic death paradigms in the MPTP mouse model of Parkinson's disease.
    Thomas B; Banerjee R; Starkova NN; Zhang SF; Calingasan NY; Yang L; Wille E; Lorenzo BJ; Ho DJ; Beal MF; Starkov A
    Antioxid Redox Signal; 2012 May; 16(9):855-68. PubMed ID: 21529244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective effects of Astilbin on MPTP-induced Parkinson's disease mice: Glial reaction, α-synuclein expression and oxidative stress.
    Zhu YL; Sun MF; Jia XB; Cheng K; Xu YD; Zhou ZL; Zhang PH; Qiao CM; Cui C; Chen X; Yang XS; Shen YQ
    Int Immunopharmacol; 2019 Jan; 66():19-27. PubMed ID: 30419450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic activation of autophagy by combined treatment with rapamycin and trehalose in a mouse MPTP-induced model of Parkinson's disease.
    Pupyshev AB; Tikhonova MA; Akopyan AA; Tenditnik MV; Dubrovina NI; Korolenko TA
    Pharmacol Biochem Behav; 2019 Feb; 177():1-11. PubMed ID: 30582934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) differs in mouse strains and reveals a divergence in JNK signaling and COX-2 induction prior to loss of neurons in the substantia nigra pars compacta.
    Boyd JD; Jang H; Shepherd KR; Faherty C; Slack S; Jiao Y; Smeyne RJ
    Brain Res; 2007 Oct; 1175():107-16. PubMed ID: 17884023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.